These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 582752)

  • 1. Chemical characterization of decomposition products of pyrazolidinedione-3,5 derivatives. Part 1: Identification of decomposition products and mechanism of degradation of 4-prenyl-1,2-diphenyl-3,5-pyrazolidine-dione in an aqueous solution.
    Wachowiak R
    Arzneimittelforschung; 1979; 29(4):599-602. PubMed ID: 582752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical characterization of decomposition products of pyrazolidinedione-3,5 derivatives. Part 2: Chemical transformations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (prenazone) and its main decomposition product N,N'-diphenylhydrazide-2-carboxy-5-methyl-4-hexenoic acid in sulphuric acid concentrated.
    Wachowiak R
    Arzneimittelforschung; 1979; 29(5):725-7. PubMed ID: 582968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical investigation of decomposition processes of pyrazolidine-3,5-dione derivatives. Part 3. Kinetics and mechanism of degradation of ketazone in aqueous solutions and solid phase.
    Wachowiak R
    Pol J Pharmacol Pharm; 1978; 30(6):833-43. PubMed ID: 39293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Differentiation of 3,5-dioxo-1,2-diphenyl-4-n-butyl-pyrazolidine (phenylbutazone) and 3,5-dioxo-1,2-diphenyl-4-prenyl-pyrazolidine (prenazone) using reaction chromatography].
    schütz C; Schütz H
    Arzneimittelforschung; 1973 Mar; 23(3):428-31. PubMed ID: 4740130
    [No Abstract]   [Full Text] [Related]  

  • 5. Physico-chemical and analytical studies on 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370).
    Perego R; Gallazzi A; Vanoni PC; Lucarella I
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:177+. PubMed ID: 5067189
    [No Abstract]   [Full Text] [Related]  

  • 6. [The stability of bromhexine and the structure of its degradation products].
    Göber B; Lisowski H; Franke P
    Pharmazie; 1988 Jan; 43(1):23-6. PubMed ID: 3375295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of Craviten decomposition in aqueous solutions.
    Kubiak Z; Kuncewicz B; Zurańska M
    Pol J Pharmacol Pharm; 1980; 32(6):917-25. PubMed ID: 7243688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoxidation and hydrolysis kinetics of the sodium salt of phenylbutazone in aqueous solution.
    Fabre H; Hussam-Eddine N; Lerner D; Mandrou B
    J Pharm Sci; 1984 Dec; 73(12):1709-13. PubMed ID: 6441841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LC and LC-MS study of stress decomposition behaviour of isoniazid and establishment of validated stability-indicating assay method.
    Bhutani H; Singh S; Vir S; Bhutani KK; Kumar R; Chakraborti AK; Jindal KC
    J Pharm Biomed Anal; 2007 Mar; 43(4):1213-20. PubMed ID: 17118610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photochemical decomposition of phenazone derivatives. Part 7: Mechanism of decomposition in aqueous solutions.
    Marciniec B
    Pharmazie; 1985 Mar; 40(3):180-2. PubMed ID: 4023033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Identification of various drugs derived from pyrazolone-5 and pyrazolidine-dione-3,5 using thin-layer chromatography and ultraviolet spectrophotometry].
    Gouezo F; Roman JP; Cristau B
    Ann Pharm Fr; 1968 Apr; 26(4):301-10. PubMed ID: 5714015
    [No Abstract]   [Full Text] [Related]  

  • 12. Chemical characterization of decomposition products of drugs. Part 5: Products of autoxidation and photo-oxidation of thioridazine hydrochloride.
    Pawelczyk E; Marciniec B
    Pharmazie; 1974 Sep; 29(9):585-5. PubMed ID: 4421012
    [No Abstract]   [Full Text] [Related]  

  • 13. Study of erythromycin A decomposition products in aqueous solution by solid-phase microextraction/liquid chromatography/tandem mass spectrometry.
    Volmer DA; Hui JP
    Rapid Commun Mass Spectrom; 1998; 12(3):123-9. PubMed ID: 9474800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The distribution and excretion of 14C- and 3H-labelled 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370) in the rat.
    Dean HG; Donovan B; Rylett P
    Arzneimittelforschung; 1976; 26(8):1574-81. PubMed ID: 1036955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolites of feprazone in man.
    Yamaguchi H; Kubo J; Sekine K; Naruchi T; Hashimoto Y; Kato R
    Drug Metab Dispos; 1979; 7(5):340-4. PubMed ID: 40778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The structure of degradation products of neostigmine bromide].
    Porst H; Kny L
    Pharmazie; 1985 May; 40(5):325-8. PubMed ID: 4034636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LC-UV-PDA and LC-MS studies to characterize degradation products of glimepiride.
    Bansal G; Singh M; Jindal KC; Singh S
    J Pharm Biomed Anal; 2008 Nov; 48(3):788-95. PubMed ID: 18804934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics and mechanism of degradation of some 5-allylbarbituric acid derivatives. Part 2: Mechanism of 5.5-diallylbarbituric acid degradation as a function of pH.
    Hermann T
    Pharmazie; 1976 Jun; 31(6):368-72. PubMed ID: 8793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of imatinib mesylate degradation products obtained under stress conditions.
    Szczepek WJ; Kosmacińska B; Bielejewska A; Łuniewski W; Skarzyński M; Rozmarynowska D
    J Pharm Biomed Anal; 2007 Apr; 43(5):1682-91. PubMed ID: 17307328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of thermography in the evaluation of the anti-inflammatory activity of feprazone on rheumatoid arthritis.
    Singer F; Gruber J; Graber J; Reinthaler M; Thumb N
    Arzneimittelforschung; 1982; 32(4):427-9. PubMed ID: 7201815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.